호흡기 진단 시장 규모 : 검사 유형별, 제품·서비스별, 최종사용자별, 지역별, 범위 및 예측
Global Respiratory Diagnostics Market Size By Test Type, By Products And Services, By End User, By Geographic Scope And Forecast
상품코드:1623511
리서치사:Verified Market Research
발행일:2024년 10월
페이지 정보:영문 202 Pages
라이선스 & 가격 (부가세 별도)
한글목차
호흡기 진단 시장 규모와 예측
호흡기 진단 시장 규모는 2020년에 46억 9,000만 달러로 평가되며, 2021-2028년 CAGR 6.3%로 성장하며, 2028년에는 79억 9,000만 달러에 달할 것으로 예측됩니다.
폐 관련 질환 및 감염성 질환 증가, 노인 인구 증가, 기술 개발 등의 요인이 시장 성장에 기여하고 있습니다. 반면, 상환 및 의료 비용 상승과 관련된 위험은 전체 시장 성장을 저해할 수 있습니다. 세계의 호흡기 진단 시장 보고서는 시장의 전반적인 평가를 제공합니다. 주요 부문, 동향, 시장 성장 촉진요인, 억제요인, 경쟁 구도 시장에서 중요한 역할을 하는 요인 등을 종합적으로 분석합니다.
세계의 호흡기 진단 시장 정의
호흡기 진단은 의료 분야와 진단센터에서 가장 많이 사용되는 기술 중 하나입니다. 시장 성장의 주요 이유는 젊은 층의 라이프스타일 변화와 노년층의 노화 관련 증상 및 질병으로 인한 것입니다.
세계의 호흡기 진단 시장 개요
폐 관련 질환 및 감염성 질환 증가, 노령 인구 증가, 기술 개발 등의 요인이 시장 성장에 기여하고 있습니다. 반면, 진료비 및 의료비 상승과 관련된 위험은 전체 시장 성장을 저해할 수 있습니다. 흡연자 증가, 알코올 섭취, 좌식 생활과 스트레스가 많은 일상 생활은 COPD와 폐암과 같은 중증 호흡기 질환의 발생률을 증가시키고 있습니다. 또한 COPD 진단 및 외래 환자 관리에 인공지능(AI)과 사물인터넷(IoT)을 활용하는 등 호흡기 진단 검사의 여러 기술 혁신이 시장 성장에 긍정적인 영향을 미치고 있습니다.
시장 성장을 저해하는 특정 억제요인과 과제도 존재하는데, COPD 진단 및 검사와 관련된 높은 가격, 진단되지 않고 치료받지 못하는 많은 인구의 존재, 엄격한 규제 요건, 인식 부족, 상환에 대한 우려와 같은 요인이 세계 호흡기 진단 시장의 성장을 억제할 것으로 예상됩니다.
목차
제1장 세계의 호흡기 진단 시장 : 서론
시장 개요
조사 범위
전제조건
제2장 개요
제3장 VERIFIED MARKET RESEARCH의 조사 방법
데이터 마이닝
밸리데이션
일차 자료
데이터 소스 리스트
제4장 세계의 호흡기 진단 시장 전망
개요
시장 역학
촉진요인
억제요인
기회
Porter's Five Forces 모델
밸류체인 분석
규제 프레임워크
제5장 세계의 호흡기 진단 시장 : 검사 유형별
개요
기계적 검사
OSA 진단 검사
영상 검사
분자진단 검사
기타
제6장 세계의 호흡기 진단 시장 : 제품·서비스별
개요
기기·디바이스
어세이와 시약
서비스와 소프트웨어
제7장 세계의 호흡기 진단 시장 : 최종사용자별
개요
병원/임상 검사실
표준실험실
의사 사무소
기타 최종사용자
제8장 세계의 호흡기 진단 시장 : 지역별
개요
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
기타 유럽
아시아태평양
중국
일본
인도
기타 아시아태평양
세계의 기타 지역
라틴아메리카
중동 및 아프리카
제9장 세계의 호흡기 진단 시장 : 경쟁 구도
개요
기업 시장 순위
벤더 구도
주요 발전 전략
제10장 기업 개요
Philips Healthcare
Becton, Dickinson & Company
Abbott Laboratories
Thermo Fisher Scientific Inc.
Alere Inc.
Bio-Rad Laboratories, Inc.
Cosmed
Seegene Inc.
Sdi Diagnostic
제11장 부록
관련 조사
KSA
영문 목차
영문목차
Respiratory Diagnostics Market Size And Forecast
Respiratory Diagnostics Market size was valued at USD 4.69 Billion in 2020 and is projected to reachUSD 7.99 Billion by 2028, growing at aCAGR of 6.3% from 2021 to 2028.
Factors such as increasing lung-related diseases and infections, the rise in the geriatric population, and technological developments are leading to growth in the market. On the other hand, risks associated with reimbursements and the rising healthcare cost might hinder the overall market growth. The Global Respiratory Diagnostics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Respiratory Diagnostics Market Definition
Respiratory Diagnostics is one of the most used technologies in the medicinal sector and diagnostic centers. The reason for the market growth is mainly the lifestyle changes in the young population and age-related symptoms and diseases in the geriatric population.
Global Respiratory Diagnostics Market Overview
Factors such as increasing lung-related diseases and infections, the rise in the geriatric population and technological developments are leading to the growth in the market. On the other hand, risks associated with reimbursements and the rising healthcare cost might hinder the overall market growth. The growing number of smokers and consumption of alcohol, along with sedentary lifestyle habits and stressful routines, have resulted in increased incidences of COPD and other severe respiratory conditions, such as lung cancer. Moreover, several technological innovations in respiratory diagnostic testing, counting the use of Artificial Intelligence (AI) and the Internet of Things (IoT) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth.
There are certain restraints and challenges faced which will hinder the market growth. Factors such as High price associated with COPD diagnosis and testing, a presence of a large population going undiagnosed and undertreated, Strict regulatory requirements, lack of awareness, and Reimbursement concerns are expected to restrain the growth of the global Respiratory Diagnostics Market.
Global Respiratory Diagnostics Market: Segmentation Analysis
Global Respiratory Diagnostics Market is segmented based on Test Type, Products and Services, End User, And Geography.
Respiratory Diagnostics Market, By Test Type
Mechanical Tests
OSA Diagnostic Tests
Imaging Tests
Molecular Diagnostic Tests
Others
Based on Test Type, the market is bifurcated into Mechanical Tests, OSA Diagnostic Tests, Imaging Tests, Molecular Diagnostic Tests, and Others. The OSA Diagnostic Tests segment is projected to account for the largest share of the market. The factors can be attributed to the quick turnaround time of these tests.
Respiratory Diagnostics Market, By Products And Services
Instruments and Devices
Assays and Reagents
Services and Software
Based on Products and Services, the market is bifurcated into Instruments and Devices, Assays and Reagents and Services & Software. The instruments and devices segment is anticipated to account for the largest share in the market. The factors can be attributed to the continuous requirement of diagnostic instruments and devices in point-of-care, laboratories, and home care.
Respiratory Diagnostics Market, By End User
Hospital/Clinical Laboratories
Reference Laboratories
Physician Offices
Other End Users
Based on End User, the market is bifurcated into Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices and Other End Users. The Hospital/Clinical Laboratories segment is expected to account for the largest share of the global market due to most respiratory disease diagnostics are done in hospitals as they are complex and need technologically advanced products this factor is driving the market for Hospital/Clinical Laboratories.
Respiratory Diagnostics Market, By Geography
North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, the Global Respiratory Diagnostics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by North America. The factors can be attributed to the growing prevalence of respiratory diseases and the increasing geriatric population in the region. Furthermore, the occurrence of an advanced healthcare system and robust distribution channels for respiratory diagnostic products are other factors supporting the growth of this market in North America.
Key Players
The "Global Respiratory Diagnostics Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Key Developments
Product Launches and Product Expansions
In June 2020, GE Healthcare launched the Thoracic Care Suite that has eight artificial intelligence (AI) algorithms that allow chest X-rays to detect abnormalities, including pneumonia detection, a symptom related to COVID-19. This new product launched by the company during the expansion of COVID-19 has enhanced the credibility of the company in the market.
On July 2020 BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, has announced the launch of three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses.
May 2020, Australian medical technology company, 4DMedical has received clearance from the US Food & Drug Administration to market its XV Technology, a patented four-dimensional lung imaging process that rapidly and automatically analyses any functional lung impairment from a single X-ray. 4DMedical's US operations are based in Woodland Hills, California.
Acquisition and Mergers
May 2020, SIME, a Clinical AI company specialising in rapid ICU diagnostics, announced it has entered into an exclusive agreement with an existing strategic investor to commercialise the company's point-of-care products and services in Latin America.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL RESPIRATORY DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL RESPIRATORY DIAGNOSTICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE
5.1 Overview
5.2 Mechanical Tests
5.3 OSA Diagnostic Tests
5.4 Imaging Tests
5.5 Molecular Diagnostic Tests
5.6 Others
6 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES
6.1 Overview
6.2 Instruments & Devices
6.3 Assays and Reagents
6.4 Services and Software
7 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY END USER
7.1 Overview
7.2 Hospital/Clinical Laboratories
7.3 Reference Laboratories
7.4 Physician Offices
7.5 Other End Users
8 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East and Africa
9 GLOBAL RESPIRATORY DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
